The Global Intra-Aortic Balloon Pump (IABP) market study provides critical information related to the global, regional and top players including Intra-Aortic Balloon Pump (IABP) market share analysis, ...

The Global Intra-Aortic Balloon Pump (IABP) market study provides critical information related to the global, regional and top players including Intra-Aortic Balloon Pump (IABP) market share analysis, ...

PARIS — Early implantation of an intra-aortic balloon pump (IABP) in patients with decompensated heart failure (HF) and low output provided more effective treatment than inotropic agents in a small ...

August 27, 2012 (Munich, Germany) — Use of an intra-aortic balloon pump (IABP) offered no mortality benefits at 30 days in the 600-patient IABP SHOCK II trial, according to Dr Holger Thiele ...

Announcing a new article publication for Cardiovascular Innovations and Applications journal. An intra-aortic balloon pump (IABP) is the device most frequently used as a bridge to surgical repair in ...

Please provide your email address to receive an email when new articles are posted on . Teleflex announced FDA clearance for an intra-aortic balloon pump for the treatment of patients with severe ...

A balloon pump inserted in the aorta is currently the most widely used support device in the treatment of cardiogenic shock and, since its introduction in 1968, has been used in several million people ...

DUBLIN--(BUSINESS WIRE)--The "US Market Report for Intra-Aortic Balloon Pumps 2018 - MedCore" report has been added to Research and Markets' offering. An intra-aortic balloon pump system is used for ...

Contrary to lackluster short-term results, elective intra-aortic balloon pump (IABP) therapy in high-risk patients receiving percutaneous coronary intervention (PCI) substantially reduces all-cause ...

Please provide your email address to receive an email when new articles are posted on . The FDA announced it has designated a recall of intra-aortic balloon pumps by Datascope/Getinge as class I, the ...

Intra-aortic balloon pump (IABP) therapy fails to reduce infarct size or improve clinical outcomes when added prior to primary percutaneous coronary intervention (PCI) in patients with high-risk ...